Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Aptose Biosciences Stock Forecast NASDAQ:APTO
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-05-10 | 471.43% | RBC Capital | $7.00 $6.00 | Maintains | Outperform |
| 2021-12-21 | 1042.86% | HC Wainwright & Co. | $14.00 $12.00 | Maintains | Buy |
| 2021-11-12 | 1233.33% | HC Wainwright & Co. | $9.00 $14.00 | Maintains | Buy |
| 2021-03-24 | 757.14% | Oppenheimer | $8.00 $9.00 | Maintains | Outperform |
| 2020-02-20 | 1423.81% | Maxim Group | $16.00 | Initiates Coverage On | Buy |
| 2020-01-09 | 852.38% | Piper Sandler | $10.00 | Initiates Coverage On | Overweight |
| 2019-08-07 | 471.43% | HC Wainwright & Co. | $8.50 $6.00 | Reiterates | Buy |
APTO Stock Trend
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.
Given the current short-term trend, the stock is expected to fall -3.62% during the next 3 months and, with a 90% probability hold a price between $0.91 and $1.39 at the end of this 3-month period.
WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-23 | $0.94 | $1.19 | $1.44 |
| 2022-05-24 | $0.94 | $1.19 | $1.44 |
| 2022-05-25 | $0.94 | $1.19 | $1.44 |
| 2022-05-26 | $0.94 | $1.19 | $1.44 |
| 2022-05-27 | $0.94 | $1.19 | $1.44 |
| 2022-05-31 | $0.94 | $1.19 | $1.44 |
| 2022-06-01 | $0.94 | $1.19 | $1.44 |
| 2022-06-02 | $0.94 | $1.19 | $1.43 |
| 2022-06-03 | $0.94 | $1.19 | $1.43 |
| 2022-06-06 | $0.94 | $1.18 | $1.43 |
| 2022-06-07 | $0.94 | $1.18 | $1.43 |
| 2022-06-08 | $0.93 | $1.18 | $1.43 |
| 2022-06-09 | $0.93 | $1.18 | $1.43 |
| 2022-06-10 | $0.93 | $1.18 | $1.43 |
| 2022-06-13 | $0.93 | $1.18 | $1.43 |
| 2022-06-14 | $0.93 | $1.18 | $1.43 |
| 2022-06-15 | $0.93 | $1.18 | $1.43 |
| 2022-06-16 | $0.93 | $1.18 | $1.43 |
| 2022-06-17 | $0.93 | $1.18 | $1.42 |
| 2022-06-21 | $0.93 | $1.18 | $1.42 |
| 2022-06-22 | $0.93 | $1.17 | $1.42 |
| 2022-06-23 | $0.93 | $1.17 | $1.42 |
| 2022-06-24 | $0.93 | $1.17 | $1.42 |
| 2022-06-27 | $0.92 | $1.17 | $1.42 |
| 2022-06-28 | $0.92 | $1.17 | $1.42 |
| 2022-06-29 | $0.92 | $1.17 | $1.42 |
| 2022-06-30 | $0.92 | $1.17 | $1.42 |
| 2022-07-01 | $0.92 | $1.17 | $1.42 |
| 2022-07-05 | $0.92 | $1.17 | $1.42 |
| 2022-07-06 | $0.92 | $1.17 | $1.41 |
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, a small molecule that induces the transcription of the Krüppel-like factor 4 Gene in in vitro studies and in in vivo pharmacodynamic studies of human xenograft tumors in mice. The companys APTO-253 clinical program has completed Phase-I clinic... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
